Base Pair Biotechnologies, founded with a mission to revolutionize ligand discovery, focuses on providing rapid, high-quality RNA- and DNA-based aptamer discovery services. The company's core offerings include custom aptamer discovery and development, bioinformatics for aptamer selection, affinity determination, and assay development services. Their market focus spans biotechnology, pharmaceuticals, and diagnostics, leveraging aptamers' advantages over traditional antibodies for various applications.
Notable affiliated individuals and investors include experts in biotechnology and life sciences, though specific names are not disclosed. Key achievements include the development of proprietary tools like AptaTracker™ for enhanced aptamer selection and maturation processes. Base Pair Biotechnologies has significantly impacted the field by accelerating the discovery of high-affinity ligands, facilitating advancements in diagnostics and therapeutic development.
